Allogeneic cord blood transplantation (CBT), especially from unrelated donors, is being increasingly used for treating paediatric patients with both malignant and nonmalignant disorders. Recent clinical and experimental evidence suggests that human cord blood mononuclear cells (CBMC) may acquire in utero a state of tolerance towards non-inherited maternal antigens (NIMA). In order to better define this phenomenon, we measured, by means of a limiting dilution assay (LDA), the frequency of NIMA-specific CTL precursors (CTLp) in cord blood samples obtained from 13 healthy neonates. Over the past decade, allogeneic cord blood transplantation (CBT) from both related and unrelated donors has been used increasingly for the treatment of paediatric patients with both malignant and non-malignant disorders.
low incidence and severity of GVHD as compared to patients given bone marrow transplantation (BMT). 5 However, few patients given CBT and developing grade III-IV disease have been reported. 4 The reported low incidence of severe GVHD after CBT is possibly due to the well-documented immature state of T and NK cord blood mononuclear cell (CBMC) subsets, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] as well as to the predominance of cord blood suppressor activity upon helper and cytotoxic T cell functions, as proved by the capacity of cord blood cells to preferentially inhibit certain immune functions of adult lymphocytes. 10, 17, 18 CBMC immaturity and prevalence of suppressor functions are consequences of poor antigenic experience 10 and foetalmaternal immunological interactions, 18 which operate to prevent both foetal rejection and GVHR towards maternal tissues during pregnancy. The absence of immunological memory determines the incapacity of CBMC to be activated in vitro by recall antigens, 19 but, apparently, does not impair the ability of these lymphocytes to proliferate and secrete lymphokines in response to allogeneic stimuli. [20] [21] [22] Even though alloantigen priming of cord blood T lymphocytes can induce a strong proliferative response, it has been demonstrated that this initial activation leads to a state of unresponsiveness of cord blood T lymphocytes when re-challenged with the same alloantigens. 23 Conflicting results have been reported on the capacity of CBMC to mediate alloreactive cytolytic activity, some authors describing a normal function 24, 25 and others an absent or reduced response. 11, [20] [21] [22] [23] 26, 27 These discrepancies, which might be due to differences in the type of stimulators used to elicit alloreactive CTL and/or in the methods of CTL evaluation, highlight the need for further investigations on this issue. Alloreactive potential of cord blood may also be shaped by foetal-maternal interactions, 18 which could determine unresponsiveness of CBMC to noninherited maternal antigens (NIMA). The occurrence of this phenomenon in humans has been clearly demonstrated to affect in vivo production of anti-HLA antibodies in multitransfused patients, 28 and the survival of renal transplants from sibling donors. 29 However, these favourable clinical effects of NIMA have not found a biological explanation, since conflicting results on development of NIMA-specific CTL have been published. [30] [31] [32] [33] [34] [35] We previously observed that CBMC from about 50% of neonates are unable to develop CTL activity when challenged in vitro with allogeneic cells in 'bulk culture' conditions. In the great majority of remaining individuals who were able to mount a cytotoxic response against paternal cells, CBMC were unable to kill cells of maternal origin. 31 In this study, we have extended these preliminary observations with a view to elucidating whether the apparent state of cytotoxic unresponsiveness towards maternal cells is due to an at least partial deletion of antigen-specific precursor populations or the presence of a suppressive environment, causing a temporary state of NIMA-specific tolerance. For this purpose, we measured by means of a limiting dilution assay (LDA) the frequency of alloreactive cord blood CTL precursors (CTLp) directed against NIMA in samples obtained from 13 healthy neonates. Results were compared to those obtained from the same cord blood samples, against non-inherited paternal antigens (NIPA). Moreover, the immune phenotype of effector cells obtained in LDA was characterised in order to define which lymphocyte subsets preferentially expand and differentiate in response to stimulation with NIMA and NIPA.
Materials and methods

Collection and preparation of blood samples
Heparinized cord blood was collected from 13 healthy neonates and peripheral blood was obtained from their mothers and fathers and from 10 unrelated healthy adult donors (aPBMC). Parents gave their informed written consent before collection of umbilical cord blood.
CBMC and PBMC were isolated by centrifugation over a Ficoll-Hypaque gradient, cryopreserved in FCS, 10% DMSO, and stored in liquid nitrogen. The medium used was RPMI 1640 (Gibco, Paisley, UK), supplemented with 2 mm l-glutamine, 50 g/ml gentamycin, and 10% FCS (RPMI-FCS) or 5% pooled human serum (RPMI-HS). In order to detect any possible contamination by maternal cells, analysis of short tandem repeat (STR) sequences was performed on all cord blood samples tested.
Cell line establishment
EBV-induced B lymphoblastoid cell lines (EBV-LCL) were established as previously described. 36 PHA blasts were obtained by culturing CBMC or PBMC in 24-well plates (5 × 10 5 cells/ml) for 72 h at 37°C and 5% CO 2 in RPMI-FCS medium, in the presence of PHA (Boehringer Mannheim, Mannheim, Germany; PHA-L, 8 g/ml).
Limiting dilution assays
Seven serial two-fold dilutions of CBMC, used as responder cells, were assayed in RPMI-HS medium. Parents' EBV-LCL or PBMC were used as stimulator cells. Each dilution of responder cells (4 × 10 4 -625 cells/well) was added to 24 replicate wells of a U-bottomed, 96-well plate in a volume of 50 l; ␥-irradiated (70 Gy for EBV-LCL and 30 Gy for PBMC) stimulator cells (2 × 10 4 EBV-LCL or 5 × 10 4 PBMC) were added in a volume of 100 l to each well. Control wells contained irradiated stimulator cells alone. Twenty-five l of RPMI-HS medium containing a final concentration of 5 U/ml of recombinant interleukin-2 (rIL-2; Hoffmann-La Roche, Nutley, NJ, USA) were added to each well on days 3 and 6. The cultures were incubated at 37°C in 5% CO 2 for 10 days.
Cytotoxicity assay
On day 10, cultures were assayed for cytolytic activity against 51 Cr-labelled targets, which included cord blood and parents' EBV-LCL or cord blood and parents' PHA blasts. Each LDA well was split, by a two-fold transfer of 80 l, and tested against allogeneic or autologous target cells in a standard 51 Cr release assay. 36 
Calculation of alloreactive CTLp frequency
Assay wells were defined as positive when 51 Cr release exceeded the average plus 3 s.d. of control wells. The frequency of responding cells was determined by maximum likelihood estimation, using a statistical program and variance by the use of 95% confidence limits. 37 Results were expressed as CTLp/million input cells.
Phenotyping
Monoclonal antibodies (mAbs) used to characterise effector cells were: CD3 (anti-Leu-4) FITC, CD4 (anti-Leu-3a) PE, CD8 (anti-Leu-2) PE, CD56 (anti-Leu-19) PE (Becton Dickinson, Mountain View, CA, USA). Proper isotype controls were used as negative controls. Cytofluorimetric analysis of cell populations, which included unstimulated CBMC and PBMC, as well as effector cells obtained from pooled positive wells of LDA, was performed by means of direct immunofluorescence on a FACScan flow cytometer (Becton Dickinson). Differences between surface antigen percentages tested before and after incubation with the different stimulator cells were analysed by Student's t-test for dependent or independent samples, as appropriate. All P values were two tailed.
Results
In preliminary experiments, LDA assays were performed by using either fresh or cryopreserved lymphocytes. Since results were comparable, cryopreserved cells were used in further experiments. STR sequence analysis of cord blood samples studied did not reveal the presence of maternal cells (data not shown).
EBV-LCL-induced alloreactive response
In each of the six LDA-experiments, CBMC were stimulated with either mothers' or fathers' EBV-LCL. After 10 days culture, each LDA well was split and cytolytic activity evaluated against both allogeneic and autologous EBV-LCL, the latter being a control for specificity ( Figure 1 ). Results show that allo-EBV-LCL were able to stimulate cytotoxic precursor cells directed against parents' targets in all cord blood samples tested, but a measurable, sometimes high, frequency of cytotoxic cells directed towards autologous EBV-LCL was also detected. Notwithstanding the presence of 'auto- reactive' cytolytic activity, which could hardly be due to the presence in cord blood of memory EBV-specific CTLp, 24 the frequency of cytotoxic precursors directed towards maternal EBV-LCL was higher than that detected against autologous EBV-LCL in six out of six samples tested. When paternal EBV-LCL were used as stimulators, the numerical frequency of cytotoxic precursors directed against paternal targets was higher than that detected against autologous EBV-LCL in four out of five samples tested, CBL2 showed a higher frequency towards autologous targets. CBL5 displayed a very low frequency against both allogeneic and autologous targets (see also Figure 1 ).
Effector cells derived from pooled positive wells of LDA were analysed for T and NK phenotype ( LCL stimulated vs unstimulated CBMC: P Ͻ 0.001; paternal EBV-LCL stimulated vs unstimulated CBMC: P Ͻ 0.001) and of CD4 + lymphocytes (maternal EBV-LCL stimulated vs unstimulated CBMC: P Ͻ 0.05; paternal EBV-LCL stimulated vs unstimulated CBMC: P Ͻ 0.05). Moreover, we observed an expansion of CD56 + /CD3 − NK cells (maternal EBV-LCL stimulated vs unstimulated CBMC: P Ͻ 0.001; paternal EBV-LCL stimulated vs unstimulated CBMC: P Ͻ 0.001), which are possibly responsible for the cytotoxic activity observed towards autologous EBV-LCL. Activation of these cells hinders a reliable quantification of cord blood alloreactive CTLp.
PBMC-induced alloreactive response
In order to avoid a preferential expansion of NK cells, the following seven cord blood samples were tested in LDA using parents' PBMC as stimulator cells and allogeneic or autologous PHA blasts as targets (Figure 3a) . Results were compared with those obtained from PBMC of five adult unrelated donors, which were stimulated with allogeneic adult PBMC and tested against PHA blasts obtained from both the stimulator and the responder donor (Figure 3b) . Results show that CTLp reactive towards PBMC of both parents were obtained in all cord blood samples tested and, altogether, CTLp frequencies observed in cord blood were comparable with those measured in aPBMC. Frequency of cytotoxic cells directed towards autologous target cells was undetectable or very low (Ͻ10 cytotoxic lymphocytes/million input cells). Therefore, parents' PBMC, used as stimulator cells, can apparently give a reliable quantification of alloreactive CTLp in cord blood. Frequency of CTLp directed towards maternal cells was substantially lower than that measured against paternal cells in three out of seven cord blood samples, but it was higher in two of them and comparable in the remaining two samples. Effector cells, derived from pooled positive wells of LDA, were analysed for T and NK phenotype and compared with unstimulated, pre-culture CBMC (Figure 4) . Results indicate that stimulation of CBMC with maternal cells, in contrast to stimulation with paternal cells (Figure 4a) , caused a significant increase in the percentage of CD3 + T cells (maternal PBMC-stimulated vs unstimulated CBMC: P Ͻ 0.01; paternal PBMC-stimulated vs unstimulated CBMC: P = NS). CD3 + /CD56 + cells significantly expanded in response to both maternal and paternal alloantigens (maternal PBMC-stimulated vs unstimulated CBMC: P Ͻ 0.001; paternal PBMC-stimulated vs unstimulated CBMC: P Ͻ 0.001). No significant variation was observed in CD3 − /CD56
+ subsets. The percentage of CD4 + cells significantly decreased after stimulation with paternal alloantigen (P Ͻ 0.05), but not following activation with maternal cells (P = NS). Maternal cells preferentially stimulated the expansion of CD3 − /CD8 + lymphocytes displaying a dim fluorescence (CD3 − /CD8 dim+ ; P Ͻ 0.05). By contrast, effector cells generated by stimulation with paternal cell (Figure  4a ), as well as those obtained after activation of aPBMC with allogeneic aPBMC (Figure 4b) , included an expanded population of CD3 + /CD8 bright+ T lymphocytes (paternal PBMC-stimulated vs unstimulated CBMC: P Ͻ 0.005; adult PBMC-stimulated vs unstimulated PBMC: P Ͻ 0.05). 
The percentage of CD3
− /CD8 dim lymphocytes was unaffected (paternal PBMC-stimulated vs unstimulated CBMC: P = NS; adult PBMC-stimulated vs unstimulated PBMC: P = NS).
Discussion
Results of this study indicate that cytotoxic lymphocyte precursors directed towards NIMA are not deleted during foetal life and, therefore, can be detected in the majority of cord blood samples. In the same cord blood sample, the relative frequencies of cytotoxic lymphocyte precursors directed towards maternal or paternal cells were not apparently dependent on the number of HLA mismatches between each child and his/her parents (data not shown). The interindividual variability of alloreactive CTLp fre- quencies in the cord blood samples studied is not surprising given that it is also commonly observed among adult healthy donors.
Our data confirm and extend previously reported data obtained with adult blood, demonstrating that challenge with NIMA in neonatal life does not lead to down-regulation of allogeneic T cell response to the mother. 32, 35 Even though NIMA are able to elicit cord blood cytotoxic lymphocyte precursors, our data document also that the majority of effector cells thus generated express a different phenotype when compared with cord blood CTLp activated by NIPA and adult peripheral blood CTLp stimulated with adult allogeneic targets. In fact, surface phenotype analysis of effector cells recovered from LDA demonstrated that stimulator cells of paternal origin induced the expansion of cord blood CD3
+ T cells displaying a bright fluorescence. This phenotype is similar to that observed in effector cells derived from LDA performed with adult peripheral blood and it is known to be associated with allospecific CTL. By contrast, stimulator cells of maternal origin favoured the expansion of cord blood CD3
− lymphocytes displaying a dim fluorescence for CD8 antigen, a phenotype reminiscent of NK cells. It is well known that human NK cells are reactive towards allogeneic targets lacking their specific killer cell inhibitory receptors (KIRs), while they are tolerant of autologous cells which express them. 38, 39 Recently, it has been reported that NK cells of donor origin, which represent the first lymphocyte subset recovering in the peripheral blood of patients given a HLA-mismatched, T cell-depleted, haematopoietic stem cell transplantation, are able to kill recipients' target cells of haematopoietic origin, but do not mediate GVHD. 40, 41 One can hypothesise that similar populations of NK cells can be activated during foetal life as a consequence of foetalmaternal immunological interactions. Subsets of NK cells able to control the overgrowth of immunocompetent maternal cells crossing the placental barrier, without mediating GVHR towards maternal tissue, might be useful for foetal survival, and their development during foetal life could be the cause for the peculiar pattern of cytotoxic response of CBMC to NIMA.
Data obtained from NIPA-stimulated cultures demonstrate that CBMC include normal numbers of alloreactive CTLp able to differentiate into effector cytotoxic cells, which express the same phenotype as allospecific CTLp found in adult peripheral blood (CD3 + /CD8 bright+ ). Therefore, the phenotype of effector cells recovered after stimulation of CBMC with NIMA does not appear to be the consequence of a reduced number of conventional alloreactive CTL precursors, but could be determined by a distinct microenvironment, peculiar to foetal-maternal immunological interaction. Since NK cells and CTL are believed to mutually regulate their development, 42 a preferential activation of the former may have a negative influence on the differentiation of alloreactive CTL.
The evidence that stimulation of CBMC with NIMA preferentially activates populations of alloreactive NK cells, possibly less able to mediate severe GVHD than alloreactive CTL, could explain a recent clinical observation on patients given CBT from HLA partially matched relatives. In fact, Wagner et al 1 reported that children transplanted from siblings disparate for NIMA experienced a lower risk of severe GVHD, as compared to those given CBT from a NIPA-mismatched donor. If confirmed in a larger cohort of patients, this clinical observation would be of interest, when only HLA-disparate unrelated donors are available for the selection of a cord blood unit, which shares non-inherited maternal rather than non-inherited paternal HLA antigens. Moreover, a persistence of this unique pattern of cord blood cytolytic response towards NIMA after the perinatal period could possibly explain why recipients of renal transplants from a HLA-haploidentical NIMA-disparate sibling enjoy a longer graft survival than patients given the kidney from a donor diverse for NIPA. 29 In keeping with previously published data demonstrating that autologous EBV-LCL are able to elicit in CBMC a strong innate immunological response mediated by both NK cells and CD4 + T lymphocytes, 43 our present data demonstrate that a similar preferential expansion of NK subsets can also be observed after activation with allogeneic EBV-LCL, and confirm evidence on the strong functional capacity of cord blood NK cells, when activated by some viral stimuli. 43 It has been reported that in humans EBV-specific immune responses may generate a CTL-mediated crossreaction with alloantigens, 44 this explains the clinical association between herpesvirus infections and GVHD. The preferential early activation of NK cord blood cells, instead of CTL, in response to some viral infections, similar to that observed after NIMA challenge, may also contribute to the low incidence and severity of GVHD in CBT recipients.
In a previous study, we documented that, when stimulated in 'bulk culture' conditions with maternal PBMC, CBMC from the great majority of neonates were able to proliferate and mediate NK-like activity, but were unable to kill cells of maternal origin. 31 This observation was apparently in keeping with data published by some authors on a blunted immune response to maternal cells or soluble HLA antigens, 30, 33, 34 but in contrast with results reported by others, 32, 35 who did not show any difference in the CTLp frequency towards NIMA and NIPA. Results of the present study indicate that absence of response in 'bulk culture' does not seem to be due to deletion of NIMA-reactive cytotoxic cells, but it can rather be attributed to the action of regulatory populations, displaying their effect in 'bulk culture' and unable to carry out their function in a limiting dilution condition. Experiments are in progress to better define the mechanism underlying this phenomenon, which may correlate with a suppressive environment, peculiar to foetal-maternal immunological interaction.
